EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Management of CML and Pregnancy in Low-and Middle-income Countries

Nitya Malhotra, Rimpy Tandon, Pankaj Malhotra iD

Indian Journal of Hematology and Blood Transfusion · 2025-01 · 41 (1) · 1-9

DOI: 10.1007/s12288-024-01930-8 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Indian Journal of Hematology and Blood Transfusion, online erschienen am 19.11.2024. Verfasst von Nitya Malhotra und 2 weiteren Autor:innen. Beteiligte Einrichtung: Govt Medical College, Sector 32, Chandigarh, India. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic myeloid leukemia (CML) is one of the most common types of leukemia observed in adults in low- and middle-income countries (LMICs). While the life expectancy of CML patients in the chronic phase in high-income countries (HIC) countries has nearly matched that of the general population, this is not the case for CML patients in LMICs. Several factors contribute to this disparity, including delayed presentation, delayed diagnosis, poor socioeconomic background, illiteracy, lack of insurance, long travel distances to healthcare facilities, limited availability of CML specialists, and the prevalence of tropical infections such as dengue and malaria. Consequently, management guidelines developed for CML patients in HIC are not always applicable to those in LMICs. The same hold true for CML patients who are pregnant or wish to conceive. This manuscript explores these differences and offers tailored recommendations for pregnancy and CML. Male patients with CML can safely father children, as neither the disease nor tyrosine kinase inhibitors (TKIs) impact pregnancy or affect newborns. However, managing CML in female patients is more complex. Although physicians advise planned pregnancies for CML patients, most pregnancies in LMICs are unplanned. Issues such as whether to continue or stop TKI treatment and which TKI to use are critical considerations. Interferon is regarded as safe during pregnancy but is seldom prescribed due to its high cost. This manuscript aims to address these complexities and provide recommendations for pregnant CML patients in LMICs including India.

Schlagwörter

Stichwörter der Autor:innen

CMLFertilityImatinibLMICPregnancy

Autor:innen und Institutionen

  • Govt Medical College, Sector 32, Chandigarh, India.
  • Dept of Clinical Hematology & Medical Oncology, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012 India.

ORCID-Profile: Pankaj Malhotra

Zitieren

APA

Malhotra, N., Tandon, R., & Malhotra, P. (2025). Management of CML and Pregnancy in Low-and Middle-income Countries. Indian Journal of Hematology and Blood Transfusion, 41(1), 1-9. https://doi.org/10.1007/s12288-024-01930-8

Vancouver

Malhotra N, Tandon R, Malhotra P. Management of CML and Pregnancy in Low-and Middle-income Countries. Indian Journal of Hematology and Blood Transfusion. 2025;41(1):1-9. doi:10.1007/s12288-024-01930-8

BibTeX
@article{Malhotra2025,
  author = {Malhotra, Nitya and Tandon, Rimpy and Malhotra, Pankaj},
  title = {Management of CML and Pregnancy in Low-and Middle-income Countries},
  journal = {Indian Journal of Hematology and Blood Transfusion},
  year = {2025},
  volume = {41},
  number = {1},
  pages = {1--9},
  doi = {10.1007/s12288-024-01930-8}
}
Kostenlos starten →